Fujiko Oh-hashi
- Biochemistry top 10%
-
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 5
- interferon and immune responses 2
-
- Cancer Research and Treatments 4
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Cytokine Signaling Pathways and Interactions 3
- Cancer Immunotherapy and Biomarkers 2
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Tateshi KataokaYoshio SakuraiTakashi TsuruoJeffrey S. JohnstonImad NaasaniWan Yong FengKenneth Chun‐Ho ChanTomoko Oh‐hara
- Journals
- Cancer Immunology Immunotherapy (4 papers)Cancer Chemotherapy and Pharmacology (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Fujiko Oh-hashi
22 papers receiving 348 citations
Peers
Comparison fields: 5 of 76
- Applied Microbiology and Biotechnology 35
- Biochemistry 70
- Immunology 123
- Pathology and Forensic Medicine 78
- Biotechnology 28
Countries citing papers authored by Fujiko Oh-hashi
This map shows the geographic impact of Fujiko Oh-hashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujiko Oh-hashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujiko Oh-hashi more than expected).
Fields of papers citing papers by Fujiko Oh-hashi
This network shows the impact of papers produced by Fujiko Oh-hashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujiko Oh-hashi. The network helps show where Fujiko Oh-hashi may publish in the future.
Co-authorship network
The 20 scholars most cited alongside Fujiko Oh-hashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. | 2003 | 173 |
| 2 | 1995 | 6 | |
| 3 | 1990 | 2 | |
| 4 | 1987 | 2 | |
| 5 | Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors. | 1985 | 35 |
| 6 | 1985 | 2 | |
| 7 | Enhancement of antiproliferation activity of vincristine and adriamycin by interferon. | 1984 | 8 |
| 8 | Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy. | 1984 | 11 |
| 9 | Tumor dependency of concanavalin A-induced potentiation of tumor cell immunogenicity. | 1983 | 5 |
| 10 | Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A. | 1982 | 14 |
| 11 | 1982 | 2 | |
| 12 | 1982 | 19 | |
| 13 | Effect of antineoplastic agents on the induction of suppressor macrophages by concanavalin A-bound tumor vaccine. | 1981 | 4 |
| 14 | In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents. | 1980 | 6 |
| 15 | Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. | 1979 | 15 |
| 16 | 1979 | 6 | |
| 17 | Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity. | 1979 | 7 |
| 18 | Effect of combined use of anticancer drugs with a polysaccharide preparation, Krestin, on mouse leukemia P388. | 1978 | 10 |
| 19 | Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor. | 1977 | 12 |
| 20 | Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A. | 1977 | 28 |
About Fujiko Oh-hashi
Fujiko Oh-hashi is a scholar working on Immunology, Biotechnology and Oncology, having authored 22 papers that have together received 382 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (5 papers), Cancer Research and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), interferon and immune responses (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (35 citations), Biochemistry (70 citations) and Immunology (123 citations). Fujiko Oh-hashi has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Tateshi Kataoka, Yoshio Sakurai, Takashi Tsuruo, Jeffrey S. Johnston, Imad Naasani, Wan Yong Feng, Kenneth Chun‐Ho Chan, Tomoko Oh‐hara, Shigeru Tsukagoshi and Yasuji Suhara. Their work appears in journals such as Cancer Immunology Immunotherapy, Cancer Chemotherapy and Pharmacology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.